Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Recent data shed light on link between subclinical thyroid disease and cardiac events
• Algorithm improved rule-in, rule-out of MI within 1 hour
• Analysis raises concerns on appropriateness of transcatheter aortic valve implantation
• Blood pressure medications may increase lip cancer risk
• CT quality improvement program helped reduce inappropriate tests
• Depression linked to peripheral arterial disease
• Dual-chamber pacemaker may be best for certain patients
• FDA clears robotic-assisted system for CAD stent procedures
• MI risk heightened after total hip and knee replacement surgery
• Joint Consensus Statement: Improved workplace wellness programs needed
• Lipid levels improving among US adolescents
• Pitavastatin shows little interaction with protease inhibitor combination in HIV
• Survey highlights need for structural heart disease training for new interventional cardiologists
• CCTA in the ED
• Icosapent ethyl capsules gain FDA approval for reduction of triglycerides
• Vascular balloon-expandable stent system receives FDA approval
• New research points to added benefits of physical activity
• New initiatives from fraud-detecting government contractors create threats for physicians Alan E. Reider, JD, MPH
• Athletes with long QT syndrome experienced few cardiac events
• Blood type may influence CHD risk
• Decrease in cardiac arrests linked to ICDs
• Enhanced post-cardiac arrest care significantly improved neurological outcomes
• Excessive sodium hidden in hospital meals
• Genetic determinant of on-treatment reactivity identified in patients treated with clopidogrel after PCI
• HF clinics rarely used despite clear benefits
• Infections linked to significantly worse outcomes in STEMI patients
• Morbidity, mortality and depression reduced with exercise in HF patients
• Neurodevelopmental outcomes not linked to surgical management in children with heart defect
• No evidence of long-term increased risk for death with endoscopic vein graft harvesting
• Oral contraceptive use in girls, alcohol consumption in boys linked to hypertension in late adolescence
• Patients with mitral regurgitation living longer after surgery
• PHIRST-2: Efficacy of tadalafil sustained long-term
• Polypill achieved large BP, cholesterol reductions in older patients
• QRS morphology more important predictor of response to CRT than QRSd
• Rhythm control linked to superior long-term outcomes vs. rate control drug treatment
• RIFLE-STEACS: Radial access improved outcomes in ACS patients
• ROMICAT II study results published
• Stroke patients hospitalized on weekends experienced poorer outcomes
• USPSTF: ECG screening still not recommended for low-risk adults
• XAMI: Second-generation EES noninferior to first-generation SES
• ASH, Mississippi State Department of Health create hypertension initiative
• Cardiology Today Editorial Board member recipient of Society of Nuclear Medicine award
• Designated Hypertension Centers program launched
• Funding will support research fellowships in low- and middle- income countries
• Henry Ford Hospital names director of new Structural Heart Disease program
• Mayo Clinic Health receives grant to improve rural health care
• Michael D. Ezekowitz, MD, PhD, joins CRF
• Peter C. Block, MD: A pioneer in interventional cardiology
• The arrhythmogenic potential of 5-HT3 antagonists: A cause for concern Cynthia Sanoski, PharmD, BCPS, FCCP; Chris Domenico, PharmD candidate
• CoCoA
• INVADE
• PHIRST-2
• PRECOMBAT-2
• PREDICT
• RIFLE-STEACS
• Whitehall II
• XAMI